| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |